» Articles » PMID: 22707395

Histopathological Algorithm and Scoring System for Evaluation of Liver Lesions in Morbidly Obese Patients

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2012 Jun 19
PMID 22707395
Citations 341
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and being overweight is a significant risk factor. The aim was to build an algorithm along with a scoring system for histopathologic classification of liver lesions that covers the entire spectrum of lesions in morbidly obese patients. A cohort of 679 obese patients undergoing liver biopsy at the time of bariatric surgery was studied. An algorithm for segregating lesions into normal liver, NAFLD, or nonalcoholic steatohepatitis (NASH) was built based on semiquantitative evaluation of steatosis, hepatocellular ballooning, and lobular inflammation. For each case, the SAF score was created including the semiquantitative scoring of steatosis (S), activity (A), and fibrosis (F). Based on the algorithm, 230 obese patients (34%) were categorized as NASH, 291 (43%) as NAFLD without NASH, and 158 (23%) as not NAFLD. The activity score (ballooning + lobular inflammation) enabled discriminating NASH because all patients with NASH had A ≥ 2, whereas no patients with A < 2 had NASH. This score was closely correlated with both alanine aminotransferase (ALT) and aspartate aminotransferase (AST) (P < 0.0001, analysis of variance [ANOVA]). Comparison of transaminase levels between patients with normal liver and pure steatosis did not reveal significant differences, thus lending support to the proposal not to include steatosis in the activity score but to report it separately in the SAF score. In the validation series, the interobserver agreement for the diagnosis of NASH was excellent (κ = 0.80) between liver pathologists. There was no discrepancy between the initial diagnosis and the diagnosis proposed using the algorithm.

Conclusion: We propose a simple but robust algorithm for categorizing liver lesions in NAFLD patients. Because liver lesions in obese patients may display a continuous spectrum of histologic lesions, we suggest describing liver lesions using the SAF score.

Citing Articles

Motor protein KIF13B orchestrates hepatic metabolism to prevent metabolic dysfunction-associated fatty liver disease.

Miao G, Zhang W, Xu Y, Liu Y, Lai P, Guo J Mil Med Res. 2025; 12(1):11.

PMID: 40038775 PMC: 11877712. DOI: 10.1186/s40779-025-00594-3.


Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease.

Boel F, Akimov V, Teuchler M, Terkelsen M, Wernberg C, Larsen F Commun Med (Lond). 2025; 5(1):56.

PMID: 40032974 PMC: 11876662. DOI: 10.1038/s43856-025-00780-3.


The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease.

Eslam M, Fan J, Yu M, Wong V, Cua I, Liu C Hepatol Int. 2025; .

PMID: 40016576 DOI: 10.1007/s12072-024-10774-3.


Using digital pathology to standardize and automate histological evaluations of environmental samples.

Tanabe P, Schlenk D, Forsgren K, Pampanin D Environ Toxicol Chem. 2025; 44(2):306-317.

PMID: 39919237 PMC: 11816309. DOI: 10.1093/etojnl/vgae038.


The Circadian Rhythm Regulates the Hepato-ovarian Axis Linking Polycystic Ovary Syndrome and Non-alcoholic Fatty Liver Disease.

Lan Y, Jin B, Fan Y, Huang Y, Zhou J Biochem Genet. 2025; .

PMID: 39826031 DOI: 10.1007/s10528-024-11010-1.